Abstract 543: SF2523, a dual PI3K-BRD4 inhibitor, enhances KRAS (G12C) or EGFR (exon 19/21) mutant targeted inhibitors in non-small-cell lung cancer (NSCLC)
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Baskaran Subramani, Patrick Joseph Conway, Kun Zhang, Guillermo A. Morales, Joseph R. Garlich, Daruka Mahadevan
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409690826